Hamps Bio Ltd is in the business of Pharmaceutical Formulation and Freeze-Drying Ingredient Manufacturing and DistributionBusiness Overview: HBL is in the business of ethical marketing and distribution of pharmaceutical formulations across wide range of dosage including tablets, syrups, capsules, injectables, oil, gel and powder used as medicine & nutrition supplements...
sHamps Bio Ltd. has announced a shift in its upcoming 18th Annual General Meeting (AGM). The company's Board of Directors has approved rescheduling the AGM from its original date of Friday, August 29, 2025, to Saturday, August 30, 2025. The meeting will still be held at 12:00 P.M. at the...
Hamps Bio Ltd. has received confirmation from its Registrar and Share Transfer Agent, Bigshare Services, regarding the status of its shares. The RTA verified that all of the company's shares are entirely held in dematerialized (electronic) form. Crucially, no requests were processed to convert any electronic shares back into physical...
Hamps Bio Ltd. has announced a board meeting following the resignation of Ms. Radhika Arun Kanodiya as a Non-Executive Independent Director due to pre-occupation and other commitments. Her resignation is effective immediately, with no other reasons cited. This change impacts the company’s board composition, potentially influencing its governance and strategic...
Hamps Bio Limited, listed on the BSE SME platform, has clarified that it is exempt from submitting Disclosure of Related Party Transactions as per Regulation 23(9) due to its SME listing status. The company will continue adhering to all other applicable listing compliance requirements. This update reassures shareholders about the...
Hamps Bio Ltd. has announced there is no deviation or variation in the use of funds raised through its Initial Public Offering of Rs. 22.20 lakh. The funds have been utilized as planned across the purchase of machinery for its FMCG division, brand awareness activities, general corporate purposes, and issue...
